Anti-VEGFR2/KDR/CD309 Antibody (Ramucirumab)
Catalog No.
F2046
Anti-VEGFR2/KDR/CD309 Antibody (Ramucirumab)
Featured Products
Ramucirumab (anti-VEGFR) is a human VEGFR-2 antagonist with anti-solid tumor effects. Ramucirumab (anti-VEGFR) is a human monoclonal antibody that binds to VEGFR-2 and prevents the binding of VEGFR ligands VEGF-A, VEGF-C and VEGF-D. Ramucirumab (anti-VEGFR) is also an angiogenesis inhibitor.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- COA (Certificate Of Analysis)
- MSDS (Material Safety Data Sheet)
- Datasheet
143.8 kDa
Dry ice
947687-13-0
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Ramucirumab
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P35968
Human, Cynomolgus
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human VGFR2 His at 4 ug/mL can bind Anti-VEGFR2/KDR/CD309 Antibody (Ramucirumab)
VEGFR2 / KDR / CD309
Please avoid freeze-thaw cycles.